Innate Pharma(IPHA) - 2022 Q4 - Annual Report

Reporting Information - The report is filed under Form 6-K for the month of April 2023[2] - The registrant has indicated it will file annual reports under Form 20-F[2] Company Information - Innate Pharma S.A. is based in Marseille, France, with a principal executive office address at 117 Avenue de Luminy—BP 30191, 13009 Marseille[2] Financial Updates - The report includes a press release dated April 6, 2023, which may contain key financial updates[3] Signatory Information - The report is signed by Mondher Mahjoubi, Chairman of the Executive Board and Chief Executive Officer[7]